Detalhe da pesquisa
1.
High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort Study.
Ann Neurol
; 95(4): 706-719, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38149648
2.
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.
Ann Neurol
; 2024 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38568026
3.
"Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis.
Ann Neurol
; 92(4): 670-685, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35748636
4.
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: A 20-year study.
Eur J Neurol
; 30(5): 1378-1388, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36692863
5.
Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients.
J Int Neuropsychol Soc
; 29(3): 283-289, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35465860
6.
Prominent role of executive functioning on the Phonemic Fluency Test in people with multiple sclerosis.
J Int Neuropsychol Soc
; 29(9): 902-906, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36781412
7.
Intrathecal versus Peripheral Inflammatory Protein Profile in MS Patients at Diagnosis: A Comprehensive Investigation on Serum and CSF.
Int J Mol Sci
; 24(4)2023 Feb 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36835179
8.
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS.
Mult Scler
; 28(4): 550-560, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34378437
9.
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients.
Mult Scler
; 28(5): 768-777, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34328817
10.
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis.
Mult Scler
; 28(13): 2090-2098, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35765211
11.
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients.
Mult Scler
; 28(12): 1937-1943, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35723265
12.
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients.
Curr Opin Neurol
; 34(3): 277-285, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33661162
13.
The CSF Profile Linked to Cortical Damage Predicts Multiple Sclerosis Activity.
Ann Neurol
; 88(3): 562-573, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32418239
14.
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis.
J Neurol
; 271(5): 2149-2158, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38289534
15.
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis.
Front Immunol
; 15: 1343892, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38404586
16.
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review.
J Neuroimmunol
; 375: 578011, 2023 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36621074
17.
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis.
J Neurol
; 270(7): 3315-3328, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37184659
18.
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis.
Ther Adv Neurol Disord
; 15: 17562864221092124, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35755969
19.
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs.
Biomedicines
; 10(12)2022 Nov 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36551795
20.
CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 8(6)2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34588298